Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
10.27
+0.02 (0.20%)
At close: Dec 29, 2025, 4:00 PM EST
10.15
-0.12 (-1.13%)
After-hours: Dec 29, 2025, 7:08 PM EST
Lexeo Therapeutics Analyst Ratings
Total Analysts
10
Consensus Rating
Strong Buy
Price Target
$18.90
Upside
+84.03%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Raymond James | Raymond James | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +143.43% | Dec 18, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +65.53% | Dec 11, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $19 | Buy | Initiates | $19 | +85.00% | Dec 1, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $19 | Buy | Initiates | $19 | +85.00% | Nov 20, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $17 | Strong Buy | Maintains | $17 | +65.53% | Nov 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $13 | Strong Buy | Maintains | $15 → $13 | +26.58% | Oct 21, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +192.11% | Oct 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $15 | Strong Buy | Maintains | $9 → $15 | +46.06% | Oct 7, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $15 → $17 | Strong Buy | Maintains | $15 → $17 | +65.53% | Oct 7, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $9 → $20 | Buy | Maintains | $9 → $20 | +94.74% | Oct 7, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $15 → $9 | Buy | Maintains | $15 → $9 | -12.37% | Aug 15, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $20 → $15 | Strong Buy | Maintains | $20 → $15 | +46.06% | Aug 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $15 → $9 | Strong Buy | Maintains | $15 → $9 | -12.37% | Aug 15, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $20 | Buy | Initiates | $20 | +94.74% | Jul 31, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $16 → $10 | Buy | Maintains | $16 → $10 | -2.63% | May 30, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $23 → $15 | Strong Buy | Maintains | $23 → $15 | +46.06% | May 16, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.